Rohit Nambisan is CEO and co-founder at Lokavant, a clinical trial intelligence platform company. The excitement around AI’s potential to solve healthcare’s biggest problems is palpable. For ...
The Phase 2 PRECEDENT Study of dalzanemdor (SAGE-718) in patients with mild cognitive impairment due to Parkinsons Disease did not meet its primary endpoint, leading to no ...